Treace Medical Concepts (TMCI)
Builds surgical systems for bunion and related midfoot deformity procedures.
$4.61
vs last close+0.02 (+0.44%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 49.42% | 32.14M shares | |
|---|---|---|---|
| 122 holders · as of Jun 30, 2026 | |||
| Insiders | 37.10% | 24.13M shares | |
| 15 holders · as of Aug 24, 2026 | |||
| Other | 13.48% | 8.76M shares | |
| remainder | |||
65.03M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
122 holders · 32.14M shares · 33 new positions · 70 increased · 33 reduced · 31 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Armistice Capital, LLC | 6.36M | 9.79% | 0 | Aug 14, 2026 |
| Bank of America Corp /DE/ | 3.31M | 5.08% | +90.8K | Aug 14, 2026 |
| Gagnon Securities LLC | 3.03M | 4.66% | −2.17M | Aug 5, 2026 |
| Vanguard Capital Management LLC | 2.03M | 3.12% | +567.0K | Aug 13, 2026 |
| Gagnon Advisors, LLC | 1.53M | 2.36% | +1.53M | Aug 5, 2026 |
| AQR Capital Management LLC | 1.50M | 2.30% | +435.8K | Aug 14, 2026 |
| BlackRock, Inc. | 1.38M | 2.12% | −1.96M | Aug 7, 2026 |
| Marshall Wace, LLP | 1.33M | 2.04% | +1.06M | Aug 13, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Armistice Capital, LLC | 9.91% | 6.26M | 13G | Aug 15, 2025 |
| Gagnon Securities LLC | 6.20% | 3.93M | 13G | Feb 12, 2026 |
| Bank of America Corp /DE/ | 5.50% | 3.53M | 13G | May 14, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 24, 2026 | John T. Treacedirector, 10 percent owner, officer: Chief Executive Officer | Purchase | 11,000 | $4.34 | 7,404,383 |
| Aug 21, 2026 | John T. Treacedirector, 10 percent owner, officer: Chief Executive Officer | Purchase | 5,000 | $4.35 | 7,393,383 |
| Aug 20, 2026 | John T. Treacedirector, 10 percent owner, officer: Chief Executive Officer | Purchase | 39,944 | $4.44 | 7,388,383 |
| Jun 10, 2026 | John T. Treacedirector, 10 percent owner, officer: Chief Executive Officer | Purchase · 2 lots | 44,145 | $4.02 | 7,353,263 |
| Jun 11, 2026 | John T. Treacedirector, 10 percent owner, officer: Chief Executive Officer | Purchase · 2 lots | 32,778 | $4.04 | 7,376,150 |
| Jun 1, 2026 | John T. Treacedirector, 10 percent owner, officer: Chief Executive Officer | Purchase | 50,000 | $3.56 | 7,323,833 |
| May 26, 2026 | John T. Treacedirector, 10 percent owner, officer: Chief Executive Officer | Purchase | 4,508 | $2.79 | 7,162,821 |
| May 27, 2026 | John T. Treacedirector, 10 percent owner, officer: Chief Executive Officer | Purchase | 49,810 | $2.87 | 7,212,631 |
| May 28, 2026 | John T. Treacedirector, 10 percent owner, officer: Chief Executive Officer | Purchase | 61,202 | $3.02 | 7,273,833 |
| May 12, 2026 | John T. Treacedirector, 10 percent owner, officer: Chief Executive Officer | Purchase | 43,000 | $2.17 | 7,047,550 |
House and Senate disclosures
Not reported.